|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| C07K 16/30 | (2006.01) | ||
| A61N 5/10 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 2621526 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11831345.1 |
| Date of filing the European patent application | 2011-09-29 | |
| (97) | Date of publication of the European application | 2013-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2018-06-06 |
| (46) | Date of publication of the claims translation | 2018-09-25 |
| (86) | Number | PCT/US2011/054054 |
| Date | 2011-09-29 |
| (87) | Number | WO 2012/047724 |
| Date | 2012-04-12 |
| (30) | Number | Date | Country code |
| 387933 P | 2010-09-29 | US |
| (72) |
SATPAEV, Daulet, US
MORRISON, Robert, Kendall, US
MORRISON, Karen Jane, Meyrick, US
GUDAS, Jean, US
JAKOBOVITS, Aya, US
TORGOV, Michael, US
AN, Zili, US
|
| (73) |
Agensys, Inc.,
1 Astellas Way Northbrook, Illinois 60062,
US
Seagen Inc., 21823 30th Drive, S.E., Bothell, WA 98021, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūno-vaisto konjugatai (ADC), kurie jungiasi prie 191P4D12 baltymų |
| ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS |
| Payment date | Validity (years) | Amount | |
| 2025-09-03 | 15 | 289.00 EUR |
| 2026-09-29 |